Saturday, October 16News That Matters
Shadow

Tag: treatment

Report: China’s treatment of Uighurs breaches every provision of U.N. genocide convention

Report: China’s treatment of Uighurs breaches every provision of U.N. genocide convention

World
March 9 (UPI) -- China's treatment of its Uighur population violates each provision of the United Nations' genocide convention, according to a damning new report published Tuesday by dozens of international law, genocide and Chinese ethnic policies experts. The report, published by the Newlines Institute for Strategy and Policy, is the first independent legal analysis comparing the United Nations' convention on genocide to the claims of human rights abuses committed by China against its Muslim minority Uighur population in northwestern Xinjiang region. Advertisement "This report concludes that the People's Republic of China bears State responsibility for committing genocide against the Uighurs in breach of the 1948 Convention on the Prevention and Punishment of the Crime of Genocide based...
Pandemic means young people face cancer treatment alone

Pandemic means young people face cancer treatment alone

Health
Teenage Cancer TrustCovid restrictions have made this year much tougher for young people already dealing with a cancer diagnosis. Sophie, like many other young cancer patients, has had to attend appointments and treatments alone, with no family or friends at her side. "My mum was crying, I was crying and she had to leave me at the door and drive off," the 24-year-old says.Last year, she was told she would need hospital treatment for five weeks, 70 miles away from home. "We had to travel to Manchester so my mum drove me," Sophie says."We got to the door and I had my suitcase - I was struggling alone with this suitcase."My mum was terrified leaving me, because she was probably thinking, 'I can't be there to comfort her,' and as well, if things go wrong, would she be walking back out of the ...
Trials begin of antibody treatment that could prevent COVID-19 in those recently exposed

Trials begin of antibody treatment that could prevent COVID-19 in those recently exposed

Technology
A new antibody treatment is being trialled amid hopes that it could prevent people from developing COVID-19 after being exposed to the disease.The antibody, known as AZD7442, has been developed by pharmaceutical company AstraZeneca and is being looked at by the University College London Hospitals NHS Trust as part of a new trial called Storm Chaser. UCLH virologist Dr Catherine Houlihan, who is leading the Storm Chaser trial, said: "We know that this antibody combination can neutralise the virus, so we hope to find that giving this treatment via injection can lead to immediate protection against the development of COVID-19 in people who have been exposed - when it would be too late to offer a vaccine."Ten people have been injected as part of the trial so far and UCLH aims to recruit 1,125 ...
Drug offers hope for acute myeloid leukemia treatment in older adults

Drug offers hope for acute myeloid leukemia treatment in older adults

Health
Dec. 24 (UPI) -- A new drug for acute myeloid leukemia, or AML, improves overall survival in people with the deadly blood cancer by up to 10 months, according to the results of a Phase 3 clinical trial published Thursday by the New England Journal of Medicine. In a study conducted at 148 hospitals in 23 countries, the drug, called CC-486, improved survival in patients age 55 and older, the data showed. Advertisement Those given the medication, a tablet formulation of the drug azacitidine, had an average survival from remission of almost 25 months, compared to 15 months for patients who did not take the drug. The U.S. Food and Drug Administration approved CC-486 in September. "It is very exciting to think that, by taking a tablet that is relatively well-tolerated, we can help reduce relap...
Princess Diana interview: Designer Matt Wiessler ‘angry’ at BBC treatment

Princess Diana interview: Designer Matt Wiessler ‘angry’ at BBC treatment

Entertainment
.css-94m6rd-HeadingWrapper{border-bottom:solid 1px #BABABA;padding-bottom:1.5rem;}.css-94m6rd-HeadingWrapper > *:not([hidden]):not(style) ~ *:not([hidden]):not(style){margin-top:1rem;}.css-vk3nhx-ComponentWrapper{margin:1.5rem 0;}.css-1759m9z-StyledFigure{font-family:ReithSans,Helvetica,Arial,freesans,sans-serif;font-weight:400;font-size:0.875rem;line-height:1.125rem;}.css-kwaqyc-StyledFigureContainer{position:relative;}.css-1xtcmof-Placeholder{position:relative;display:block;padding-bottom:56.25%;background-color:#EEEEEE;}.css-1xtcmof-Placeholder img{overflow:hidden;position:absolute;top:0;right:0;bottom:0;left:0;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-pack:center;-webkit-justify-content:center;-ms-flex-pack:center;justify-content:center;-webk...